The FDA warns of potential ills associated with medical marijuana

The Centers for Disease Control and Prevention has warned Americans of the potential for ills linked to medical marijuana, citing a study which found a link between the drug and a number of serious health conditions.

The FDA has also issued a warning about the “unhealthy and potentially life-threatening effects” of the drug known as “Sativex” on its website, and the FDA has recommended that anyone using the drug to treat epilepsy and other medical conditions to seek medical advice from a doctor.

In a recent study published in the Journal of the American Medical Association, researchers from the University of Pennsylvania and Johns Hopkins University found that “S.

dulcis, the main active ingredient in cannabis, increased the risk of dying from various causes including cancer, heart disease, stroke, and other conditions.”

The FDA said the agency was also “deeply concerned” by a recent review of the safety of SativeX.

“We continue to be concerned about the potential harmful effects of cannabis use,” the agency said in a statement.

“In recent years, studies have linked marijuana to serious adverse health effects, including death.

Further studies are needed to determine if the potential health impacts of marijuana use are due to its ability to alter normal neural functions.”

While the FDA is urging the use of marijuana to treat medical conditions, it also warns against the use for recreational purposes, which are banned by the federal government.

“There are many reasons why people may choose to use marijuana,” the FDA said.

“For example, medical conditions like epilepsy and cancer may cause people to use cannabis for relief from pain, and cannabis can alleviate nausea and vomiting, as well as decrease the frequency of stomach and intestinal infections.

Some patients may also use cannabis to ease stress or depression.

The FDA also noted that some people may benefit from the use, while others may experience side effects.”

The agency did not explain the reason for its recommendation, but it is likely to be used by patients who have suffered from chronic pain, such as chronic painkiller painkillers.

In November, the DEA also warned of a number of health risks associated with marijuana use, including cancer.

The agency also warned against the dangers of smoking marijuana and marijuana oil.

The DEA said that its investigation of marijuana’s possible harms began in October 2014, and continued in February 2015, when it found the drug in its “top priority” list of “potentially hazardous substances.”

In its announcement of its 2016 marijuana review, the agency recommended that states adopt new laws that would require medical marijuana to be grown in “closed, controlled facilities.”

The DEA is also asking states to increase fines for violations, but those penalties have been cut from $20,000 to $15,000.

The Trump administration has also been a vocal critic of marijuana legalization efforts.

The Drug Enforcement Administration said in February that it was moving forward with plans to revoke licenses for state-legal marijuana producers and distributors, and to launch raids against those operating legal dispensaries.

The move would mark the first time the DEA has launched such a raid, although the agency has used raids to target medical marijuana operations for years.

The crackdown comes after the Drug Enforcement Agency announced plans to shut down medical marijuana businesses across the country.

The DEA said the plan would target dispensaries in the same states where they were already targeting dispensaries.

“Today’s announcement comes on the heels of an FDA report on the medical value of cannabis and the recent DEA announcement that it is seeking to revoke state-license-granting licenses for cannabis businesses,” said David S. Goldstein, the director of the Drug Policy Alliance, in a news release.

“It’s a move that will have devastating effects on the state-licensed cannabis industry.”

The Drug Policy Action group said in its statement that the move “undermines the credibility of the DEA’s claims that medical marijuana is safe and effective, and will cause more people to seek illegal, dangerous medical marijuana treatments.”

“It’s no wonder Trump is taking this stance,” said Matt Barber, the group’s deputy communications director.

“He knows full well that Trump wants to shut up and let the industry grow.”